ANLVSBBOT• 12 Months (Normalized)
ANL vs BBOT (Adlai Nortye Group Ltd. vs BridgeBio Oncology Therapeutics Inc.)
Showing Closing Date Range from Oct 2, 2025 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ANL Performance $15.09
+750.14%
Adlai Nortye Group Ltd.
Normalized Baseline0.00%
BBOT Performance $3.89
-68.73%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin ANL LEADS
+818.87 pts
ANL outperforming by 818.87 percentage points
ANLBBOT
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ANL BBOT
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(251 dates)
| Date | ANL Price | ANL Gain (%) | BBOT Price | BBOT Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $15.09 | +750.14% | $3.89 | -68.73% | +818.87% |
| Sep 30, 2026 | $- | $4.10 | -67.04% | - | |
| Sep 29, 2026 | $- | $3.92 | -68.49% | - | |
| Sep 28, 2026 | $- | $3.81 | -69.37% | - | |
| Sep 25, 2026 | $- | $3.95 | -68.25% | - | |
| Sep 24, 2026 | $15.83 | +791.83% | $3.99 | -67.93% | +859.76% |
| Sep 23, 2026 | $15.75 | +787.32% | $4.16 | -66.56% | +853.88% |
| Sep 22, 2026 | $16.60 | +835.21% | $4.66 | -62.54% | +897.75% |
| Sep 21, 2026 | $15.57 | +777.18% | $4.66 | -62.54% | +839.72% |
| Sep 18, 2026 | $15.74 | +786.76% | $4.77 | -61.66% | +848.42% |
| Sep 17, 2026 | $15.28 | +760.85% | $4.89 | -60.69% | +821.54% |
| Sep 16, 2026 | $15.52 | +774.37% | $4.76 | -61.74% | +836.11% |
| Sep 15, 2026 | $15.00 | +745.07% | $4.88 | -60.77% | +805.84% |
| Sep 14, 2026 | $15.93 | +797.46% | $5.05 | -59.41% | +856.87% |
| Sep 11, 2026 | $15.21 | +756.90% | $4.95 | -60.21% | +817.11% |
Page 1 of 17